Minimally invasive glaucoma surgeries offer patients an important midway step between constant drops and significant surgery.
Options such as trabecular meshwork bypass stents and microstents have become key treatments for a disease that can cause a lot of problems for patients.
“Let’s remember that there are still patients going blind from glaucoma every day,” Healio/OSN Board Member Nathan M. Radcliffe, MD, said. “With standard treatments, most patients who have glaucoma still get worse, and it creates a lot of disability.”
While pharmacologic options have been to